Legal & General Group Plc lifted its position in West Pharmaceutical Services, Inc. (NYSE:WST) by 11.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 68,745 shares of the medical instruments supplier’s stock after acquiring an additional 7,287 shares during the quarter. Legal & General Group Plc owned 0.09% of West Pharmaceutical Services worth $6,618,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in shares of West Pharmaceutical Services by 0.3% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 10,735 shares of the medical instruments supplier’s stock worth $1,015,000 after acquiring an additional 34 shares during the last quarter. Teacher Retirement System of Texas lifted its holdings in shares of West Pharmaceutical Services by 0.7% in the 2nd quarter. Teacher Retirement System of Texas now owns 5,867 shares of the medical instruments supplier’s stock worth $555,000 after acquiring an additional 40 shares during the last quarter. Hillsdale Investment Management Inc. lifted its holdings in shares of West Pharmaceutical Services by 0.7% in the 2nd quarter. Hillsdale Investment Management Inc. now owns 12,080 shares of the medical instruments supplier’s stock worth $1,142,000 after acquiring an additional 80 shares during the last quarter. Utah Retirement Systems lifted its holdings in shares of West Pharmaceutical Services by 1.5% in the 2nd quarter. Utah Retirement Systems now owns 13,400 shares of the medical instruments supplier’s stock worth $1,266,000 after acquiring an additional 200 shares during the last quarter. Finally, Commerce Bank lifted its holdings in shares of West Pharmaceutical Services by 1.4% in the 2nd quarter. Commerce Bank now owns 15,765 shares of the medical instruments supplier’s stock worth $1,490,000 after acquiring an additional 215 shares during the last quarter. Hedge funds and other institutional investors own 93.28% of the company’s stock.

Shares of West Pharmaceutical Services, Inc. (WST) traded up $0.51 on Friday, reaching $98.73. 653,817 shares of the company were exchanged, compared to its average volume of 282,221. West Pharmaceutical Services, Inc. has a one year low of $77.97 and a one year high of $103.36. The company has a market cap of $7,370.00, a price-to-earnings ratio of 42.35, a price-to-earnings-growth ratio of 2.10 and a beta of 1.12. The company has a quick ratio of 1.87, a current ratio of 2.59 and a debt-to-equity ratio of 0.15.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings data on Thursday, October 26th. The medical instruments supplier reported $0.67 earnings per share for the quarter, beating analysts’ consensus estimates of $0.53 by $0.14. West Pharmaceutical Services had a net margin of 12.12% and a return on equity of 14.47%. The company had revenue of $398.20 million during the quarter, compared to analyst estimates of $386.02 million. During the same quarter last year, the business posted $0.53 EPS. The firm’s revenue for the quarter was up 5.7% on a year-over-year basis. equities analysts predict that West Pharmaceutical Services, Inc. will post 2.76 EPS for the current year.

WST has been the subject of several analyst reports. Jefferies Group upgraded shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and raised their target price for the stock from $96.00 to $115.00 in a report on Friday, September 15th. Bank of America lowered shares of West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 target price for the company. in a report on Tuesday, October 17th. Wells Fargo & Company raised their target price on shares of West Pharmaceutical Services from $105.00 to $112.00 and gave the stock an “outperform” rating in a report on Friday, October 27th. Zacks Investment Research upgraded shares of West Pharmaceutical Services from a “sell” rating to a “hold” rating in a report on Wednesday, September 27th. Finally, Stephens started coverage on shares of West Pharmaceutical Services in a report on Tuesday, October 3rd. They set an “equal weight” rating and a $99.00 price objective for the company. One analyst has rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $106.00.

In related news, CFO William J. Federici sold 21,000 shares of West Pharmaceutical Services stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $99.01, for a total transaction of $2,079,210.00. Following the completion of the sale, the chief financial officer now owns 190,493 shares in the company, valued at approximately $18,860,711.93. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.90% of the company’s stock.

WARNING: “Legal & General Group Plc Has $6.62 Million Stake in West Pharmaceutical Services, Inc. (WST)” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/12/16/legal-general-group-plc-has-6-62-million-stake-in-west-pharmaceutical-services-inc-wst.html.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Stock Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related stocks with our FREE daily email newsletter.